Search Share Prices
AZN Headlines - AstraZeneca maintains guidance after strong start to year, buoyed by fast-growing oncology portfolio
AstraZeneca PLC has achieved a feat that not many companies will manage this year – it maintained its sales and earnings guidance after a strong opening three months. Standout f ...
Analysts upbeat on the outlook for Astrazeneca
The Astrazeneca (LON:AZN) share price has risen by 20.3% over the past month and it’s currently trading at 8241. For investors considering whether to buy, hold8230; ...
AstraZeneca PLC may be the UK's largest company, but it and other pharma giants rely in small-cap biotech for new medicines, according Arix pair
Arix is a backer of innovative smaller life sciences companies developing potentially breakthrough new medicines ...
AstraZeneca (LON:AZN) Given Overweight Rating at Barclays
AstraZeneca (LON:AZN)‘s stock had its “overweight” rating reaffirmed by research analysts at Barclays in a research report issued on Monday, ThisIsMoney.Co.Uk reports. A number of other research firms ...
Tony Zook Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc.
BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company") today appointed Mr. Anthony ('Tony') Zook to the Board of Directors of its majority-owned subsidiary ViralClear Pharmaceuticals, ...